CVS Health Corp. cut bonuses for some employees because of last year’s low profit levels, a sign that the healthcare conglomerate is still trying to recover from setbacks that led up to the ouster of ...
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
Bearish flow noted in CVS Health (CVS) with 13,937 puts trading, or 2x expected. Most active are Mar-25 60 puts and Feb-25 63 puts, with total ...
Shares tumbled after The Wall Street Journal reported that the insurer is under Justice Department investigation.
The new civil fraud investigation is examining UnitedHealth's practices for recording diagnoses that trigger extra payments ...
(Reuters) - The U.S. Justice Department has launched a probe into UnitedHealth's Medicare billing practices in recent months, ...
CVS Health Corp. closed 19.39% short of its 52-week high of $80.75, which the company reached on March 28th.
2d
Hosted on MSNCVS Health Stock Gets RS Rating UpgradeCVS Health stock received a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73. Please watch the video ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results